Skip to main content

Merck & Co., Inc.

corporate_fare Company Profile

Merck & Co., Inc.

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Exchange: NYSESector: Life Sciences

show_chartPrice Chart

Loading chart...

feed MRK - Latest Insights

MRK
Apr 24, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
MRK
Apr 21, 2026, 11:50 AM EDT
Source: Reuters
Importance Score:
8
MRK
Apr 21, 2026, 6:51 AM EDT
Source: Reuters
Importance Score:
8
MRK
Apr 20, 2026, 7:29 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
MRK
Apr 13, 2026, 4:06 PM EDT
Source: Wiseek News
Importance Score:
8
MRK
Apr 08, 2026, 4:25 PM EDT
Filing Type: DEF 14A
Importance Score:
8
MRK
Mar 30, 2026, 4:04 PM EDT
Source: Wiseek News
Importance Score:
9
MRK
Mar 30, 2026, 11:48 AM EDT
Source: Reuters
Importance Score:
9
MRK
Mar 29, 2026, 11:49 AM EDT
Source: Reuters
Importance Score:
8
MRK
Mar 25, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
MRK
Mar 24, 2026, 9:03 PM EDT
Source: Reuters
Importance Score:
9
MRK
Mar 05, 2026, 3:04 PM EST
Source: Wiseek News
Importance Score:
8
MRK
Feb 28, 2026, 10:08 AM EST
Source: Reuters
Importance Score:
8
MRK
Feb 28, 2026, 10:03 AM EST
Source: Reuters
Importance Score:
8
MRK
Feb 27, 2026, 10:28 AM EST
Source: Dow Jones Newswires
Importance Score:
9
MRK
Feb 27, 2026, 10:24 AM EST
Source: Reuters
Importance Score:
8
MRK
Feb 24, 2026, 4:15 PM EST
Filing Type: 10-K
Importance Score:
8
MRK
Feb 03, 2026, 6:38 AM EST
Filing Type: 8-K
Importance Score:
8